Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for adjunctively treating prostatic disease

An adjuvant therapy, prostate technology, applied in drug combinations, urinary system diseases, pharmaceutical formulations, etc., can solve the problems of ineffective control of diseases, poor efficacy, etc., to prevent and improve prostate diseases, improve resistance, and prevent prostate cancer. Effect

Inactive Publication Date: 2011-09-14
WUHAN JINJUYE BIOTECH
View PDF1 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] Due to the extremely complicated pathology of prostate disease, if these herbal medicines are used alone, not only the curative effect is poor, but also the patient may not be able to prescribe the right medicine, and the disease cannot be effectively controlled.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for adjunctively treating prostatic disease
  • Medicine for adjunctively treating prostatic disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] The medicine for auxiliary treatment of prostate disease of the present invention is made of the following raw materials in parts by weight: 160 mg of Saw palmetto extract, 25 mg of Pygeum africana extract, 20 mg of pumpkin seed extract, 10 mg of lycopene and 3 mg of zinc.

[0030] Preparation method: the main ingredients are mixed in proportion with saw palmetto extract, pygeum africana extract, pumpkin seed extract, lycopene and zinc, and soybean oil, soybean lecithin, glycerin and gelatin are used as auxiliary materials. Sol, press pellets, and dry to make soft capsule preparations.

[0031] Usage and dosage: twice a day, take one soft capsule each time, orally.

Embodiment 2

[0033] The medicine for auxiliary treatment of prostate disease of the present invention is made of the following raw materials in parts by weight: 180 mg of Saw palmetto extract, 30 mg of Pygeum africana extract, 30 mg of pumpkin seed extract, 15 mg of lycopene and 5 mg of zinc.

[0034] The preparation method is the same as in Example 1.

[0035] Usage and dosage: twice a day, take one soft capsule each time, orally.

Embodiment 3

[0037] The medicine for auxiliary treatment of prostate disease of the present invention is made of the following raw materials in parts by weight: 160 mg of Saw palmetto extract, 25 mg of Pygeum africana extract, 20 mg of pumpkin seed extract, 3 mg of lycopene and 2 mg of zinc.

[0038] The preparation method is the same as in Example 1.

[0039] Usage and dosage: twice a day, take one soft capsule each time, orally.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a medicine for adjunctively treating prostatic diseases, which is a medicament prepared from the following raw materials and pharmaceutically acceptable auxiliary materials in parts by weight: 160-260 parts of sabal extracts, 25-72 parts of pygeum topengii extracts, 20-80 parts of pumpkinseed extracts, 3-20 parts of lycopene and 2-15 parts of zinc. The medicine is used for treating the prostatic diseases by taking the sabal extracts and the pygeum topengii extracts as main raw materials; the synergistic effect is enhanced through the pumpkinseed extracts to play an important role in enhancing the bioavailability of the effectively components of the sabal extracts; the antioxidant ability of organisms and the resistance can be enhanced through the lycopene; and the risks of prostatic cancers is reduced by preventing and improving the prostatic diseases through the lycopene and the zinc; the medicine provided by the invention accords with the traditional Chinese medicine theory and has more scientific formula and more outstanding effect; through clinical verification, the medicine has better curative effect on the prostatic diseases; in addition, the medicine provided by the invention can be taken for a long time without toxic side effect and has the effects of disease prevention and treatment.

Description

technical field [0001] The invention relates to a medicine, in particular to a medicine for auxiliary treatment of prostate diseases. Background technique [0002] Prostate disease is a disease with high incidence and difficult treatment. It generally includes acute and chronic prostatitis, bacterial prostatitis, benign prostatic hyperplasia, prostate cancer, etc. It is a common disease that plagues men. Common symptoms of prostate disease are frequent urination, urgency, painful urination, dripping white, low back pain, and even sexual dysfunction. The clinical symptoms of prostate disease are complex and often prone to recurrence. [0003] At present, the main treatment methods for prostatitis are drugs and surgery. However, due to the special physiological structure of the prostate, it is difficult for ordinary drugs to enter the interior of the prostate through a layer of hard fatty membrane wrapped around the outside of the prostate; moreover, due to the special path...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/889A61P13/08A61K31/01A61K33/30
Inventor 傅明武
Owner WUHAN JINJUYE BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products